PHASE-II ANTIBODY TRIAL OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-HER2 NEU X ANTI-CD64) COMBINED WITH GM-CSF IN PATIENTS WITH ADVANCED PROSTATE AND RENAL-CELL CARCINOMAS THAT EXPRESS HER2/NEU/

Authors
JAMES N ATHERTON P KOLETSKY A TCHEKMEDYIAN N CURNOW R
Citation
N. James et al., PHASE-II ANTIBODY TRIAL OF THE BISPECIFIC ANTIBODY MDX-H210 (ANTI-HER2 NEU X ANTI-CD64) COMBINED WITH GM-CSF IN PATIENTS WITH ADVANCED PROSTATE AND RENAL-CELL CARCINOMAS THAT EXPRESS HER2/NEU/, British Journal of Cancer, 78, 1998, pp. 56-56
Citations number
NO
Categorie Soggetti
Oncology
Journal title
British Journal of Cancer → ACNP
ISSN journal
00070920
Volume
78
Year of publication
1998
Supplement
2
Pages
56 - 56
Database
ISI
SICI code
0007-0920(1998)78:<56:PATOTB>2.0.ZU;2-V